SCHEMBL14035115

SCHEMBL14035115

CCCCOC(=O)COc1ccc2c(-c3ccccc3C(=O)OCC)c3ccc(=O)cc-3oc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.51
KMT2A Q03164 3/20 0.47
ALDH1A1 P00352 3/20 0.47
HPGD P15428 2/20 0.47
GAA P10253 2/20 0.46
MAPT P10636 2/20 0.46
TP53 P04637 1/20 0.46
GLA P06280 1/20 0.46
MAPK1 P28482 1/20 0.46
HSD17B10 Q99714 1/20 0.46
MEN1 O00255 2/20 0.45
POLB P06746 1/20 0.45
ABCB1 P08183 1/20 0.44
EGFR P00533 10/20 0.44
USP2 O75604 1/20 0.43
CFTR P13569 1/20 0.43
PAX8 Q06710 1/20 0.43
ATM Q13315 1/20 0.43
GOPC Q9HD26 1/20 0.43
ESR1 P03372 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10205410 0.92 ABCB1 (0.48) KDM4EKMT2AALDH1A1TP53MAPK1
SCHEMBL14008335 0.91 KDM4E (0.51) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL14035116 0.90 KDM4E (0.50) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL14008331 0.89 KDM4E (0.48) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL14008329 0.89 KDM4E (0.50) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL28520428 0.89 ABCB1 (0.48) KDM4EKMT2AALDH1A1HPGDGAA
SCHEMBL28265381 0.85 PTPN11 (0.43) ALDH1A1TP53MAPK1ABCB1EGFR
SCHEMBL28265380 0.85 PTPN11 (0.43) ALDH1A1TP53MAPK1ABCB1EGFR
SCHEMBL10205413 0.85 PTPN11 (0.54) KMT2AMEN1POLBABCB1USP2
SCHEMBL21974831 0.84 ABCB1 (0.44) KDM4EKMT2AALDH1A1HPGDGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis COMMISSARIAT A L'ENERGIE ATOMIQUE (FR) 2008-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080275215-A1 Fluorescein-Based Compounds And Their Use For Peptide Synthesis DNPEP, ANPEP, PEPD KDM4E 4808/4885KMT2A 4722/4885ALDH1A1 3716/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.